FDA Approves Abecma To Treat Multiple Myeloma
The U.S. Food and Drug Administration (FDA) approved Abecma (idecabtagene vicleucel), a cell-based gene therapy to treat adult patients with multiple myeloma who have not…
The U.S. Food and Drug Administration (FDA) approved Abecma (idecabtagene vicleucel), a cell-based gene therapy to treat adult patients with multiple myeloma who have not…
Zealand Pharma announced on March 22, that the U.S. Food and Drug Administration (FDA) has approved Zegalogue (dasiglucagon) injection for the treatment of severe hypoglycemia…
The US Food and Drug Administration (FDA) recently writes an article about a growing interest in a drug called ivermectin to treat humans with COVID-19….
The U.S. Food and Drug Administration (FDA) recently granted approval for Amondys 45 (casimersen) injection for the treatment of Duchenne muscular dystrophy (DMD) in patients…
On the February 9, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for bamlanivimab and etesevimab (monoclonal antibodies) administered together for…
On January 2, the U.S. Food and Drug Administration approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human…
On December 28, the U.S. Food and Drug Administration approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit,…
Recently. Almirall, S.A., a global biopharmaceutical company focused on skin health, announced that Klisyri (tirb anibulin) has been approved by the U.S. Food and Drug…
On December 21, the U.S. Food and Drug Administration approved Ebanga (Ansuvimab-zykl), a human monoclonal antibody, for the treatment of ebola (zaire ebolavirus) infection in…
On December 2, CVS Health was selected today by the U.S. Department of Health and Human Services (HHS), as part of Operation Warp Speed, to…